IDE and Glucose intolerance: On the other hand, studies have confirmed that ginsenoside Rb1 can upregulate the expression of NMDAR1 and insulin-degrading enzyme (IDE) by suppressing CDK5/p35 activity, thereby decreasing streptozotocin (STZ)-induced glucose intolerance and insulin resistance, and consequently improving memory impairment in mice [178].